Novartis AG shareholder Artisan Partners said the Swiss drugmaker needs to shake up its board and improve dealmaking after its shares plunged following three major clinical trial setbacks, Reuters reported.
Novartis AG shareholder Artisan Partners said the Swiss drugmaker needs to shake up its board and improve dealmaking after its shares plunged following three major clinical trial setbacks, Reuters reported.
Lire l’article complet sur le site source
Bloomberg — Markets (EN)